Search

everythinglearnresearchcommunity

for

Search:↓

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Biomedical engineers are crucial for developing better treatments for chronic and autoimmune diseases.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Targeting the skin's endocannabinoid system could help treat skin disorders.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

New mouse models of Pemphigus show severe symptoms and need better treatments.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

People with autoimmune skin diseases often have hearing problems and should get their hearing checked early.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.